Self Defense

Market Movers
Non-Lethal Self-Defense
Self Defense

Byrna Technologies Inc. (BYRN): Non-Lethal Defense Solutions

Featured Content Byrna Technologies Inc. (BYRN) is a technology company specializing in non-lethal self-defense products. Byrna’s flagship product, the Byrna HD, is a compact, handheld launcher that deploys non-lethal projectiles filled with irritant substances like pepper spray or tear gas. Designed for personal safety, the Byrna HD provides an effective way to deter threats without […]

Read More
Non-Lethal Self-Defense
Self Defense
Trade Of The Day

Byrna Technologies Inc. (BYRN): Leading The Non-Lethal Defense Revolution

Featured Content Byrna Technologies Inc. is a technology company specializing in non-lethal self-defense solutions. Their flagship product is the Byrna HD, a handheld, CO2-powered device that launches chemical irritant projectiles designed to incapacitate an attacker without causing permanent injury. Byrna’s mission is to provide consumers with safer alternatives to firearms, offering personal security solutions that […]

Read More
Security
Security Technology
Self Defense
Trade Of The Day

Byrna Technologies Inc. (BYRN): Strategic Growth in the Self-Defense Market

Byrna Technologies Inc. is a leading provider of non-lethal personal security devices designed for self-defense, law enforcement, and security applications. The company’s flagship product, the Byrna HD, is a handheld launcher that fires chemical irritant projectiles designed to incapacitate an attacker without causing permanent harm. The Byrna HD is marketed as a safe, effective alternative […]

Read More
Biopharmaceuticals
Daily Rundown
Furniture
Medical Devices
Self Defense

Self Defense, Biopharmaceuticals, Medical Devices, Furniture

Byrna Technologies Inc. (BYRN) Byrna Technologies Inc., a less-lethal self-defense technology company, engages in the development, manufacture, and sale of less-lethal personal security solutions in the United States, South Africa, Europe, South America, Asia, and Canada. Y-mAbs Therapeutics, Inc. (YMAB) Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therapeutic […]

Read More